Naprod Life Sciences Private Limited — Gemcitabine Exporter Profile
Indian Pharmaceutical Exporter · #11 for Gemcitabine · $1.1M export value · DGFT Verified
Naprod Life Sciences Private Limited is the #11 Indian exporter of Gemcitabine with $1.1M in export value and 45 verified shipments. Naprod Life Sciences Private Limited holds a 2.4% market share in Gemcitabine exports across 13 countries. The company exports 23 pharmaceutical products worth $18.7M across 4 therapeutic categories.
Naprod Life Sciences Private Limited — Gemcitabine Export Profile: Buyers & Destinations
Where Does Naprod Life Sciences Private Limited Export Gemcitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $620.3K | 17 | 61.4% |
| PHILIPPINES | $143.9K | 6 | 14.3% |
| SOUTH AFRICA | $110.5K | 5 | 10.9% |
| MEXICO | $47.2K | 1 | 4.7% |
| KENYA | $33.2K | 5 | 3.3% |
| INDONESIA | $11.5K | 2 | 1.1% |
| MYANMAR | $8.7K | 3 | 0.9% |
| NIGERIA | $8.4K | 1 | 0.8% |
| MOLDOVA,REPUBLIC OF | $7.3K | 1 | 0.7% |
| NEPAL | $7.1K | 4 | 0.7% |
Naprod Life Sciences Private Limited exports Gemcitabine to 13 countries. The largest destination is BRAZIL accounting for 61.4% of Naprod Life Sciences Private Limited's Gemcitabine shipments, followed by PHILIPPINES (14.3%) and SOUTH AFRICA (10.9%). These destinations reflect Naprod Life Sciences Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gemcitabine from Naprod Life Sciences Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FARMA VISION IMP E EXP DE MEDICAMEN | BRAZIL | $563.5K | 15 |
| MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $143.9K | 6 |
| FARMA VISION IMP E EXP | BRAZIL | $56.8K | 2 |
| ABSOLUTE BROKERAGE CUSTOMS | MEXICO | $47.2K | 1 |
| OETHMAAN BIOSIMS (PTY) LTD. | SOUTH AFRICA | $43.8K | 2 |
| OETHMAAN BIOSIMS (PTY) LTD | SOUTH AFRICA | $43.6K | 2 |
| RIPPLE PHARMACUTICALES LTD. | KENYA | $23.4K | 4 |
| OETHMAAN BIOSIMS PTY LIMITED | SOUTH AFRICA | $23.1K | 1 |
| RIPPLE PHARMACUTICALES LTD, | KENYA | $9.8K | 1 |
| PT. KIMIA FARMA TBK | INDONESIA | $9.3K | 1 |
Naprod Life Sciences Private Limited supplies Gemcitabine to 20 buyers globally. The largest buyer is FARMA VISION IMP E EXP DE MEDICAMEN (BRAZIL), followed by MULTICARE PHARMACEUTICALS PHILIPPIN (PHILIPPINES) and FARMA VISION IMP E EXP (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gemcitabine Export Value and How Much Does Naprod Life Sciences Private Limited Contribute?
India exported $36.6M worth of Gemcitabine through 2,938 shipments from 248 suppliers to 125 countries, serving 676 buyers globally. Naprod Life Sciences Private Limited contributes $1.1M to this total, accounting for 2.4% of India's Gemcitabine exports. Naprod Life Sciences Private Limited ships Gemcitabine to 13 countries through 20 buyers.
What Is the Average Shipment Value for Naprod Life Sciences Private Limited's Gemcitabine Exports?
Naprod Life Sciences Private Limited's average Gemcitabine shipment value is $25.3K per consignment, based on 45 shipments totaling $1.1M. The largest destination is BRAZIL (61.4% of Naprod Life Sciences Private Limited's Gemcitabine exports).
How Does Naprod Life Sciences Private Limited Compare to Other Indian Gemcitabine Exporters?
Naprod Life Sciences Private Limited ranks #11 among 248 Indian Gemcitabine exporters with a 2.4% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($6.9M), EUGIA PHARMA SPECIALITIES LIMITED ($5.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($5.8M). Naprod Life Sciences Private Limited processed 45 shipments to 13 destination countries.
What Gemcitabine Formulations Does Naprod Life Sciences Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GEMCITABINE FOR INJECTION USP 1GM (GEMCI | $187.4K | 4 |
| Gemcitabine For Injection USP 1gm | $71.6K | 2 |
| GEMCITABINE FOR INJECTION USP 1GM(GEMCIT | $50.0K | 1 |
| GEMCITABINE FOR INJECTION USP 1GM GEMCITABINE FOR INJECTION USP 1GM 13438 VIALS | $50.0K | 1 |
| GEMCITABINE FOR INJECTION USP 1GM (GEMCITABINE FOR INJECTION USP 1GM) (7902 VIALS)VLS | $50.0K | 1 |
| GEMCITABINE FOR INJECTION USP 1GM (GEMCITABINE FOR INJECTION USP 1GM) (11000 VIALS) | $50.0K | 1 |
| GEMCITABINE FOR INJECTION USP 1GM GEMCITABINE FOR INJECTION USP 1GM 6148 VIALS | $49.1K | 1 |
| GEMCITABINE FOR INJECTION USP 1GM (GEMCITABINE FOR INJECTION USP 1GM) (6722 VIALS) | $47.2K | 1 |
| Abingem-1gm (Gemcitabine Hydrochloride Injection 1gm) (1000 VIALS) | $45.9K | 2 |
| GEMCITABINE 1G OETHMAAN (GEMCITABINE FOR | $43.8K | 2 |
Naprod Life Sciences Private Limited exports 41 distinct Gemcitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GEMCITABINE FOR INJECTION USP 1GM (GEMCI with 4 shipments worth $187.4K.
Regulatory Requirements: Exporting Gemcitabine to Key Markets
What Naprod Life Sciences Private Limited must comply with to export Gemcitabine to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Naprod Life Sciences Private Limited Compare to Nearest Gemcitabine Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | MYLAN LABORATORIES LIMITED | $1.6M | 32 | 1 | $50.0K |
| 10 | ADLEY FORMULATIONS PRIVATE LIMITED | $1.4M | 39 | 4 | $35.2K |
| 11 | NAPROD LIFE SCIENCES PRIVATE LIMITED ★ | $1.1M | 45 | 13 | $25.3K |
| 12 | RR PHARMACEUTICALS PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
| 14 | GETWELL PHARMA INDIA PRIVATE LIMITED | $295.2K | 67 | 5 | $4.4K |
Naprod Life Sciences Private Limited ranks #11 among 248 Indian Gemcitabine exporters. Average shipment value of $25.3K compared to the market average of $147.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and ADLEY FORMULATIONS PRIVATE LIMITED.
Which Indian Ports Ship Gemcitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 538 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 393 | 13.4% |
| SAHAR AIR | 370 | 12.6% |
| DELHI AIR | 358 | 12.2% |
| Delhi Air | 131 | 4.5% |
| HYDERABAD ICD (INSNF6) | 88 | 3.0% |
| Bombay Air | 77 | 2.6% |
| NHAVA SHEVA SEA (INNSA1) | 66 | 2.2% |
What Other Oncology Products Does Naprod Life Sciences Private Limited Export?
Naprod Life Sciences Private Limited also exports these oncology products. Each links to the detailed product page.
About Naprod Life Sciences Private Limited
Naprod Life Sciences Private Limited exports 23 products worth $18.7M. Beyond Gemcitabine, top products include Carboplatin, Fluorouracil, Oxaliplatin, Methotrexate, Paclitaxel. View the complete Naprod Life Sciences Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Naprod Life Sciences Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 48 individual customs records matching Naprod Life Sciences Private Limited exporting Gemcitabine, covering 41 formulations to 13 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 125+ countries, 676+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gemcitabine Export Data from Naprod Life Sciences Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Naprod Life Sciences Private Limited's Gemcitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Naprod Life Sciences Private Limited
Full Company Profile →
23 products · $18.7M total trade · 4 categories
Gemcitabine Stats
Company Overview
Top Products by Naprod Life Sciences Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Naprod Life Sciences Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gemcitabine. For current shipment-level data, contact TransData Nexus.